Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis

NCT02569333 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2020-02-28

No results posted yet for this study

Summary

Hospitalized patients with ulcerative colitis (UC) are at increased risk for a variety of complications such as infections, venous thrombosis, and surgery. The literature has revealed significant variation in the quality of care to hospitalized UC patients. As a result, guidelines for the management of these patients have been developed. However, the update of guidelines are variable. Admission to hospital can also have significant impact on quality of life due to interruptions in life commitments and lost sense of control of disease. Maintaining a sense of self-control of disease and active participation in care has been shown to be valuable among individuals with chronic diseases. The investigators propose the development of a multi-site, patient centred initiative aimed at improving clinical and patient-centered outcomes through an educational iPad based tool for patients admitted to hospital with ulcerative colitis.

Conditions

  • Colitis, Ulcerative
  • Inflammatory Bowel Diseases
  • Colitis
  • Intestinal Disease

Interventions

OTHER

Educational video

iPad with educational video highlighting current guidelines for the management of hospitalized patients with ulcerative colitis.

Sponsors & Collaborators

  • University of British Columbia

    collaborator OTHER
  • University of Calgary

    collaborator OTHER
  • University of Manitoba

    collaborator OTHER
  • University of Ottawa

    collaborator OTHER
  • McGill University

    collaborator OTHER
  • University of Alberta

    collaborator OTHER
  • Dalhousie University

    collaborator OTHER
  • Mount Sinai Hospital, Canada

    lead OTHER

Principal Investigators

  • Adam V. Weizman, MD, MSc · MOUNT SINAI HOSPITAL

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2019-01-31
Completion
2020-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02569333 on ClinicalTrials.gov